Shukra Pharmaceuticals Ltd — Board Meeting, 03-10-2025: Board Meeting
03-10-2025 | 06:51 pm
03-10-2025 | 06:51 pm
Board approved a preferential issue of 4.64 Cr convertible equity warrants to promoters at Rs. 34/warrant, totaling Rs. 15.79 Cr. Shareholder approval via EGM on Nov 1, 2025, is required. Warrants convert to shares within 18 months.
No comments yet. Be the first to comment!
